Preliminary evaluation of esophageal varices in patients with hepatitis B related cirrhosis by LSP score based on liver stiffness measurement, spleen diameter and platelets
LIU Cheng-shuai1, WU Xian-quan1, ZHANG Pu2, SONG Kun3
1. Department of Gastroenterology, Zibo Hospital of Peking University Medical College, Shandong 255000, China; 2. Department of Hepatobiliary Surgery,Zibo Hospital of Peking University Medical College, Shandong 255000, China; 3. Department of Gastroenterology, Zichuan District Hospital of Traditional Chinese Medicine, Zibo, Shandong 255000
LIU Cheng-shuai, WU Xian-quan, ZHANG Pu, SONG Kun. Preliminary evaluation of esophageal varices in patients with hepatitis B related cirrhosis by LSP score based on liver stiffness measurement, spleen diameter and platelets[J]. Chinese Hepatolgy, 2023, 28(12): 1426-1425.
[1] Garcia-Tsao G, Abraldes JG, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology, 2017, 65(1):310-335. [2] 盛基尧, 刘水, 杨永生, 等. 肝硬化门静脉高压症食管胃静脉曲张出血诊疗进展.中华外科杂志, 2020, 58(10):808-812. [3] 中华医学会外科学分会脾及门静脉高压外科学组. 肝硬化门静脉高压症食管、胃底静脉曲张破裂出血诊治专家共识(2019版).中华外科杂志, 2019, 57(12):885-892. [4] Tsuji Y, Namisaki T, Kaji K, et al. Comparison of serum fibrosis biomarkers for diagnosing significant liver fibrosis in patients with chronic hepatitis B. Exp Ther Med, 2020, 20(2):985-995. [5] Dong H, Xu C, Zhou W, et al. The combination of 5 serum markers compared to FibroScan to predict significant liver fibrosis in patients with chronic hepatitis B virus. Clin Chim Acta, 2018, 483:145-150. [6] Liao Y, Gong J, Zhou W, et al. Serum liver fibrosis markers discriminate significant liver inflammation in chronic hepatitis B patients with normal or near-normal alanine aminotransferase. J Med Virol, 2019, 91(4):642-649. [7] Stefano JT, Guedes LV, de Souza AAA, et al. Usefulness of collagen type IV in the detection of significant liver fibrosis in nonalcoholic fatty liver disease. Ann Hepatol, 2021, 20:100253. [8] Yu XY, Song XX, Tong YL, et al. Usefulness of controlled attenuation parameter and liver stiffness measurement for detecting increased arterial stiffness in asymptomatic populations in China. Medicine (Baltimore), 2020, 99(48):e23360. [9] Qu Y, Song YY, Chen CW, et al. Diagnostic performance of FibroTouch ultrasound attenuation parameter and liver stiffness measurement in assessing hepatic steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Clin Transl Gastroenterol, 2021, 12(4):e00323. [10] 中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版). 中国肝脏病杂志(电子版), 2019, 11(4): 5-27. [11] 中华医学会消化内镜学分会. 食管胃静脉曲张内镜下诊断和治疗规范试行方案(2003年). 中华消化内镜杂志, 2004, (3):149-151. [12] Boregowda U, Umapathy C, Halim N, et al. Update on the management of gastrointestinalvarices. World J Gastrointest Pharmacol Ther, 2019, 10(1):1-21. [13] Merli M, Nicolini G, Angeloni S, et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol, 2003, 38(3):266-272. [14] McDonald SA, Barclay ST, Hutchinson SJ, et al. Uptake of endoscopic screening for gastroesophageal varices and factors associated with variceal bleeding in patients with chronic hepatitis C infection and compensated cirrhosis, 2005-2016: a national database linkage study. Aliment Pharmacol Ther, 2019, 50(4):425-434. [15] 中国肝炎防治基金会, 中华医学会感染病学分会, 中华医学会肝病学分会和中国研究型医院学会肝病专业委员会. 瞬时弹性成像技术诊断肝纤维化专家共识(2018年更新版). 中华肝脏病杂志, 2019, 27(3):182-191. [16] 王洁, 黄杰安. 无创指标预测食管胃底静脉曲张破裂出血风险的研究进展. 中华胃肠内镜电子杂志, 2016, 3(3):121-124.